What is a drug launch?
A drug launch is the process of introducing a new pharmaceutical product to the market after receiving regulatory approval. It involves a series of strategic, commercial, and logistical steps to ensure the drug reaches healthcare providers and patients effectively.
Key Phases of a Drug Launch
- Pre-Launch Phase (Preparation and Planning)
- Regulatory Approval: Obtain clearance from agencies like the FDA (U.S.), EMA (Europe), or MHRA (UK).
- Market Access and Pricing Strategy: Conduct early market access planning and historic launch analog analysis. Set reimbursement, pricing and payer negotiation strategies.
- Determine Access Barriers: Map the patient journey to understand referral patterns, barriers and cost of care.
- KOL and HCP Engagement: Collaborate with Key Opinion Leaders (KOLs) and educate Healthcare Professionals (HCPs) about the drug.
- Launch Execution (Market Entry and Promotion)
- Brand Awareness and Marketing: Establish a brand website with dynamic coverage look-up for patients and providers.
- Sales Force Deployment: Train sales teams to educate doctors, pharmacists, and healthcare organizations.
- Medical Affairs and Real-World Evidence (RWE): Monitor new coverage wins and track payer and provider feedback to refine messaging.
- Patient Assistance Programs (PAPs): Consider establishing financial support programs to assist patients with access and adherence to your treatment.
- Post-Launch (Growth and Expansion)
- Monitoring and Market Feedback: Track adoption rates, prescriptions, and patient/physician feedback. Refine your target HCP list and messaging.
- Competitor Analysis: Adapt strategies based on competitor actions and market trends.
- Label Expansion and New Indications: Explore additional approvals for expanded uses of the drug.
Challenges in Drug Launches
- Market Access Barriers: Limited payer coverage and/or restrictive utilization management can slow brand uptake.
- Physician and Patient Awareness: Ensuring HCPs understand the drug’s benefits, use cases, and testing required for eligibility.
- Regulatory and Compliance Hurdles: Meeting strict guidelines on promotion and marketing.
- Supply Chain and Distribution Issues: Ensuring a stable supply without shortages.
Successful drug launches require a well-coordinated effort between regulatory, commercial, medical, and supply chain teams to maximize patient impact and commercial success.
To hear tips and tricks for a successful launch execution, watch our on-demand webinar series, Best Practices in Market Access.
